TARS - Tarsus Pharmaceuticals GAAP EPS of -$0.88 revenue of $2.5M May, 10 2023 10:00 AM Tarsus Pharmaceuticals Inc. 2023-05-10 10:00:22 ET Tarsus Pharmaceuticals press release ( NASDAQ: TARS ): Q1 GAAP EPS of -$0.88. Revenue of $2.5M (+363.0% Y/Y). For further details see: Tarsus Pharmaceuticals GAAP EPS of -$0.88, revenue of $2.5M